可用性
医学
理解力
连续血糖监测
系统可用性量表
胰岛素
家庭医学
内科学
计算机科学
人机交互
网站的可用性
程序设计语言
血糖性
作者
Deborah M. Mullen,Richard M. Bergenstal,Mary L. Johnson,Eda Cengiz,Amy Criego,Larry C. Deeb,Robin Goland,Justen Rudolph,Kathleen Cecilia Arnold,Davida Kruger,Sara Richter
标识
DOI:10.1177/26350106251337486
摘要
PurposeThe purpose of the 2-phase study was to determine patient/family and clinician design preference, usability, and comprehension of ambulatory glucose profile (AGP) reportsMethodsA cross-sectional research design employing 2 phases was conducted. Patients and parents (n = 139) reviewed an educational guide and AGP report during a clinician consultation. They were directed to identify glucose trends before answering a design preferences and usability survey. Clinicians (n = 17) completed questionnaires about patients and personal experiences, design preferences, and expected future usability. Further study of the AGP (n = 21) evaluated a draft display AGP continuous glucose monitoring (CGM) + pump report, enhanced after the aforementioned blood glucose monitoring (BGM) and CGM survey through interviews using both scripted and unscripted questions.ResultsPatients identified glucose trends/patterns in all AGP reports (100% BGM; 98% CGM; 95% CGM + pump). Patients and clinicians felt that the single-page report added value both in and outside of the clinic, preferred this standardized data view compared to traditional device-specific reports, and saw value in the AGP combination of statistics and graphs. Insulin data were seen as useful but increased the difficulty of report interpretation; only 38% were able to accurately interpret the data and make self-treatment recommendations.ConclusionsPatients feel that the AGP report (BGM, CGM, CGM + pump) is useful for identifying new glucose patterns/trends. Patients report more confidence in making self-care adjustments (behavioral, lifestyle, and treatments) using the AGP report. For shared decision-making, the AGP report serves both patients' and clinicians' needs.
科研通智能强力驱动
Strongly Powered by AbleSci AI